How Can AI Help Physicians Finish Charting? A Four-Week Trial

Coding Liquids tutorial cover featuring Sagnik Bhattacharya for How Can AI Help Physicians Finish Charting? A Four-Week Trial.
Coding Liquids tutorial cover featuring Sagnik Bhattacharya for How Can AI Help Physicians Finish Charting? A Four-Week Trial.

A physician group can trial an AI scribe over four weeks by timing notes before the trial, giving it to two clinicians, recording consent, logging every error, and measuring minutes per note and after-hours charting against that baseline. A written go or no-go rule, agreed before week one, decides the outcome. No saving is assumed in advance.

Demos are persuasive and averages in vendor material come from other people's clinics. Your own notes, your own record system and your own patient mix are what count. A short, measured trial turns "everyone says it helps" into a number you can put in front of the partners, whichever way it comes out.

Follow me on Instagram@sagnikteaches

What the trial has to answer

Write three questions on a page before you contact a vendor. First: does total time per note, including editing, fall for the clinicians in this group? Second: does the evening and weekend charting that clinicians complain about shrink? Third: are the notes accurate and safe enough that a clinician would sign them without a nervous second pass? If the answer to the third is no, the first two stop mattering.

Connect on LinkedInSagnik Bhattacharya

Notice what is missing: patient satisfaction, revenue, headline hours saved. Those can come in a later phase. A four-week trial with two clinicians has too little data to say anything firm about them, and chasing them makes the trial vague. Keep the measures few and checkable.

Subscribe on YouTube@sagnikteaches

The shape of four weeks

WeekWhat happensWhat you record
0 (setup)Agreements, settings, consent script, mock-consultation practiceBaseline sample of 20 notes per clinician
1Scribe on a limited set of appointment types, with the clinician checking every noteMinutes per note, edit time, errors
2All suitable appointments for both cliniciansSame measures, plus after-hours charting minutes
3Continue; the clinician reviews the error log with the leadSame, plus the clinicians' written comments
4Final measures, decision meetingTotals against the baseline and the go or no-go rule

Week zero is the easiest to skip, and it is the one that makes the rest meaningful. Without it you compare the scribe with a vague memory of how long notes used to take.

The Complete Excel Course with AI Integration thumbnail

The Complete Excel Course with AI Integration

From formulas and pivot tables to Power Query, DAX, VBA and AI with Copilot, ChatGPT and Claude — hands-on from the first lesson.

By Sagnik Bhattacharya and Virginia Thorn, Primetime Emmy Award winner

Buy now

Setting the baseline: minutes per note before anything changes

Pick two clinicians, say one who documents in the room and one who documents afterwards. For two weeks before the trial, each notes down the time spent on documentation for a sample of 20 consultations. A stopwatch app or a start and end time in a simple sheet is enough. Record the appointment type, the minutes spent typing or dictating during the visit, the minutes spent finishing after it, and any evening or weekend time on charting for that day.

An illustrative baseline for one clinician: a follow-up appointment of 15 minutes, with 4 minutes of note-making in the room and 5 minutes finishing afterwards, averaging 9 minutes per note. Across a 22-patient day that is about 198 minutes, and the clinician reports roughly 50 of those happening after the clinic closes. Those numbers are invented for the example; yours will differ, and the useful part is that you now have them.

Decide at this point what "a note" means. If a letter or referral is part of it, include its time or leave it out for everyone. Define it once, write it on the sheet and stick to it.

Choosing the two clinicians and the appointment types

An AI scribe behaves very differently across appointment types. A routine follow-up of a stable condition is the best test, and a complex first visit with an interpreter, or a consultation in which three people speak at once, is the hardest. For the first trial, restrict to two or three appointment types you see often and that you consider low-complexity. Add harder ones in week two or three if the early results are safe.

The clinicians matter as much as the tool. Choose one person who wants it to work and one who doubts it will. The first will push it hard and the second will read the notes more critically. If both are enthusiastic, the error log will be thinner than reality, and the group will be surprised later.

Week zero rehearsal with a mock consultation

Before any real patient is recorded, each clinician runs three mock consultations with a colleague playing the patient, using an invented history. The aim is not to test the vendor but to learn the tool's habits: how it handles interruptions, accents, a phone ringing, two people talking, medication names and numbers. Compare each draft with what was actually said and log the differences in the same error log you will use in the trial, marked as rehearsal.

An illustrative rehearsal finding: the draft correctly captured the symptoms but wrote the medication as taken "twice daily" when the colleague had said "twice a week". That is a serious-class error caught safely in a rehearsal, and it tells both clinicians to say doses and frequencies clearly and to check them first when reviewing. Rehearsal also surfaces practical problems, such as where to put the device so the audio is clear, and whether the template headings match the way the group writes notes.

Reading a draft note the careful way

Teach both clinicians the same review routine, because inconsistent checking will muddy the data. A sensible order is: first the plan and any medication, since errors there carry the highest risk; then negatives and sides (left or right, "no" and "not"); then history items and dates; and only last the wording. A before and after shows the idea. The clinician said: "No known drug allergies, but she mentioned a rash with penicillin as a child." An illustrative draft recorded: "Allergies: penicillin rash in childhood. No other known allergies." That is acceptable once the clinician confirms it, since the nuance was kept, but a draft that said "No known drug allergies" alone would be a moderate error, because it dropped the rash.

Ask each clinician to time the review separately from the rest of the note, so you can see whether checking gets faster over four weeks. If it does, that only shows up over several weeks, which is part of why a trial longer than a week is worth running.

Consent, recording and the agreements you need first

Do this before a single real consultation is recorded. Check three things with the vendor and your own governance lead:

  1. Where the audio and transcript go, how long they are kept and whether they are used to train models. Vendors differ and defaults can change between versions, so read the current terms, not a summary.
  2. Whether the vendor will sign the data-processing or business associate agreement your group needs, and whether it works with your record system.
  3. Whether your group's own policy and the patient information you give out cover recording, with an opt-out for any patient.

The tutorial on AI scribe security: audio, retention and BAA questions has the vendor-side list in full. If any of the three is unresolved, run the trial with staged consultations instead, where colleagues or volunteers play patients with invented histories. You will still learn how accurate the notes are, though you cannot measure real-world interruptions as well.

A short consent script

The clinician reads the same few sentences every time. An illustrative wording to adapt, then check with your governance lead:

"I'd like to use a tool that listens to our conversation and writes a first draft of my notes, so I can look at you more and type less. The recording is handled the way our privacy notice describes, and I check and correct every note myself. You are free to say no, and it won't change your care at all. Is that all right?"

Record each yes or no in the record in a consistent place. Count the refusals; a high refusal rate in a trial is a finding. Whenever a patient says no, the consultation proceeds as normal and the baseline timing continues, which means those consultations still produce useful comparison data.

The error log: the part that decides whether it is safe

Every note the scribe drafts gets a quick review, and anything wrong goes in a shared log. Keep one row per error with six columns: date, clinician, appointment type, what the scribe wrote, what was true, and severity. Define severity in plain terms before the trial starts:

  • Minor: wording or order, no change to meaning.
  • Moderate: an omission or inaccuracy that would matter if it were left uncorrected, such as a missing symptom or wrong side.
  • Serious: an error that could change a decision or harm a patient if signed, such as a wrong dose, an invented finding or a reversed negation ("no chest pain" recorded as "chest pain").

An illustrative week-one entry: the clinician said the patient had "no history of falls", and the draft recorded "history of falls". Severity: serious, caught on the clinician's read-through. Log what kinds of errors recur, because they tell you which parts of the consultation you must always check, and what training or settings might help. The tutorial on a checklist for AI scribe note errors lists the errors to look for.

Also log where the scribe saved time or was surprisingly good. A trial that records only failures is as skewed as one that records only wins.

What to measure each week

Keep the sheet to a handful of columns so people actually fill it in. For each consultation: appointment type, minutes of documentation in the room, minutes finishing afterwards (including the review of the scribe's draft), consent given, number of edits and severity of any errors. Once a week, each clinician adds the number of minutes they spent on charting outside clinic hours that week, as a single figure.

An illustrative week-two summary for one clinician: 54 consultations, average 6.5 minutes total per note compared with 9 at baseline, after-hours charting of about 70 minutes over the week compared with about 250. Errors: 11 minor, 3 moderate, 0 serious. Those figures are made up to show the shape of the data, and a real trial may find no saving at all, or a saving only for some appointment types. Both are useful results, so write down the possibility that it does not help before you begin.

Do not discount editing time. The easiest trap is to count the minutes the scribe saves in the room and forget the minutes the clinician spends correcting it afterwards. Time per note means start to signed, end to end.

Two clinicians, two kinds of result

Suppose the documenter-in-the-room clinician sees her total time per note fall, mostly because she no longer types while talking, and says she is more present with patients. The finishes-later clinician finds that his editing takes almost as long as his old dictation, because his notes are brief and structured and the scribe's drafts are long. Both are valid. The trial's conclusion could be that the tool suits some documentation styles better than others, which is useful for deciding who gets it first.

Watch the sceptic's comments closely. If the sceptic says "I still do not trust it, but I'd miss it", that tells you something a time measure cannot. If the enthusiast says "great" and the error log shows moderate errors she did not catch until a later review, that tells you something too.

Writing the go or no-go rule before week one

The rule is a short paragraph, agreed with a named partner or medical lead, that says what results would make you proceed, extend or stop. An illustrative example, which you must adjust to your own tolerances:

  • Go to a wider pilot if, for both clinicians, median time per note (end to end) is lower than baseline, after-hours charting does not rise, there are no serious errors that reached a signed note and the clinicians both say they want to continue.
  • Extend for two weeks if the time result is mixed or the sample for one appointment type is too small to judge.
  • Stop if any serious error was signed into a record, if time per note rose, or if the vendor's terms change in a way your governance lead cannot accept.

Notice that there is no "promised saving" threshold such as "20 per cent faster". You are not testing a vendor's claim, you are checking whether your clinicians are better off and your patients are safe. If you are already weighing costs, the tutorial on whether an AI scribe is worth it for a small private clinic shows how to turn time into a money figure afterwards.

Running the weekly review

A short fifteen-minute meeting each Friday keeps the trial honest. The agenda is fixed: the numbers for the week, the new entries in the error log, one thing each clinician wants changed in the settings or template, and a decision about whether to widen or narrow the appointment types. Write the decision and its reason in a line, so later readers can see how the trial developed.

A typical mid-trial adjustment is a template change. If the scribe's drafts bury the plan in the middle of a long narrative, adjust the note template so the plan is a separate heading. If a clinician always dictates the examination findings aloud, speak them in a consistent order. Small habits make a large difference to output quality, so write them down and keep a short "how to talk to the scribe" sheet.

What a failed trial looks like, and why it is still worth it

An illustrative failure: after four weeks, median time per note is unchanged, the error log has two serious entries in week one that were both caught before signing, and the sceptic reports spending more time proofreading than typing. The enthusiastic clinician is happy. The rule says stop or extend, and the group extends by two weeks with the sceptic using a different template and the enthusiast taking on more appointment types. At six weeks the sceptic's time per note has fallen below baseline and the serious errors have disappeared. The group still does not roll out to everyone; it offers the tool to clinicians who want it, with the error check as a standing habit.

A trial that ends in a clear stop is also worth the effort. You have spent a few weeks of two people's attention, not the licence fees for the whole group for a year. And you have your own baseline to repeat, in a year, when the products will have changed. For a wider view of the jobs AI can do in a private practice, see AI tools for physicians in private practice.

After the trial: how to roll out without losing trust

If the answer is go, resist the temptation to switch everyone on at once. Add clinicians in small groups, give each the "how to talk to the scribe" sheet and the consent script, keep the error log going for the first month and re-run the baseline measure for the new clinicians. Tell patients plainly what you are doing and how to opt out. The tutorial on rolling out an AI scribe without losing patient trust goes through that stage.

Keep a standing rule: the clinician reads and signs every note, and the log stays open. The scribe drafts; a doctor is responsible. If you would rather design the trial with someone, that is what my AI implementation consultation covers, and I would keep the same rule of thumb either way: write the stop rule first, then press record.

Questions to settle before the trial starts

Why only two clinicians?

Two is enough to see a difference between styles and small enough to supervise closely. One clinician gives you an anecdote, and a whole group gives you a rollout you have not earned. Pick one who is enthusiastic and one who is sceptical, because the sceptic will find the errors.

Can we trial it on real patients?

Only with the right agreements and consent in place. Check the vendor's data terms, retention and any business associate agreement first, and get each patient's agreement before recording. If your governance is not ready, trial on staged mock consultations instead.

What if the scribe's notes need a lot of editing?

Then the editing time is your finding. Record it. A scribe that moves work from typing to proofreading may still help, but only if the total time per note falls and the error log stays clean.

Should we compare different scribe products?

Not in the first trial. Changing two things at once makes the results hard to read. Trial one product, fix your measures, and compare others later using the same protocol.

Who signs off the go or no-go decision?

A named partner or medical lead agrees the rule before week one. Writing the rule beforehand stops a good demo or a bad week from changing the goalposts.

Further reads

Sources: general trial-design practice; vendor retention and agreement terms to be checked on the chosen vendor's own pages. No vendor performance claims are made in this tutorial.

Want your scribe trial designed before you buy licences?

On a 1:1 call we'll set your baseline measures, shape the trial for two clinicians and write down the go or no-go rule, so the decision rests on your own numbers.

Book a 1:1 call with me